EULAV Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-50,094
Closed -$2.72M 321
2015
Q2
$2.72M Hold
50,094
0.14% 210
2015
Q1
$2.75M Hold
50,094
0.14% 212
2014
Q4
$2.71M Hold
50,094
0.15% 213
2014
Q3
$2.83M Hold
50,094
0.15% 205
2014
Q2
$2.77M Hold
50,094
0.15% 209
2014
Q1
$2.71M Hold
50,094
0.15% 205
2013
Q4
$2.39M Hold
50,094
0.13% 228
2013
Q3
$2.28M Sell
50,094
-1,258
-2% -$57.4K 0.13% 225
2013
Q2
$2.28M Buy
+51,352
New +$2.29M 0.14% 223

Other funds holding MRK

EULAV Asset Management's MRK Position: Q3 2015 in Review

EULAV Asset Management sold out of Merck (MRK) in Q3 2015, closing a stake of 50,094 shares — an estimated $2.72M sold.

EULAV Asset Management first reported a position in MRK in Q2 2013 and held it in 9 quarters. The position peaked at $2.83M in Q3 2014. 1,672 funds tracked by Wall St. Rank hold MRK as of Q3 2015.

  • EULAV Asset Management reported no remaining Merck position as of Q3 2015 after selling out during the quarter.
  • EULAV Asset Management sold 50,094 Merck shares in Q3 2015, an estimated $2.72M.
  • EULAV Asset Management first reported a position in Merck in Q2 2013 and held it in 9 quarters.
  • EULAV Asset Management's Merck position peaked at $2.83M in Q3 2014.
  • 1,672 funds tracked by Wall St. Rank held Merck as of Q3 2015.

Based on EULAV Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.